Cimetidine Liquid Clinical Trials

• A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
  ClinicalTrials.gov Identifier: NCT00002092 - Completed
  HIV Infections
  
• Performance of Cimetidine-Corrected MDRD Equation in Renal Transplant Patients
  ClinicalTrials.gov Identifier: NCT00475059 - Recruiting
  Kidney Transplantation
  
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection: Canada
  ClinicalTrials.gov Identifier: NCT00162188 - Recruiting
  HIV Infection
  
• Study of Topiramate Administered as Liquid or Sprinkles in Infants (Aged 1-23 Months) With Refractory POS
  ClinicalTrials.gov Identifier: NCT00233012 - Active, not recruiting
  Seizures
  
• Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
  ClinicalTrials.gov Identifier: NCT00528216 - Active, not recruiting
  Pain
  
• Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of MEDI-493, Synagis
  ClinicalTrials.gov Identifier: NCT00233064 - Active, not recruiting
  Chronic Lung Disease
  
• A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals’ HRV Liquid Vaccine in Healthy Infants.
  ClinicalTrials.gov Identifier: NCT00432380 - Active, not recruiting
  Rotavirus Gastroenteritis
  
• Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents
  ClinicalTrials.gov Identifier: NCT00207519 - Active, not recruiting
  Overweight; Obesity
  
• A Study in Infants to Test Two Preparations (Freeze-Dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
  ClinicalTrials.gov Identifier: NCT00382772 - Active, not recruiting
  Gastroenteritis
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00002733 - Active, not recruiting
  Stage IV Melanoma; Stage IV Renal Cell Cancer; unspecified adult solid tumor, protocol specific
  
• Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children
  ClinicalTrials.gov Identifier: NCT00425087 - Active, not recruiting
  Sialorrhea; Cerebral Palsy; Neurological Condition; Mental Retardation
  
• A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00175877 - Active, not recruiting
  Rheumatoid Arthritis
  
• Evaluation of Liquid vs. Tablet Buprenorphine - 6
  ClinicalTrials.gov Identifier: NCT00000341 - Active, not recruiting
  Opioid-Related Disorders
  
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
  ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
  HIV Infections
  
• High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
  ClinicalTrials.gov Identifier: NCT00247143 - Recruiting
  HIV; AIDS
  
• A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160641 - Active, not recruiting
  Rheumatoid Arthritis
  
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
  Chronic Hepatitis B
  
• Bio-Availability of a New Liquid Tumeric Extract
  ClinicalTrials.gov Identifier: NCT00542711 - Not yet recruiting
  Healthy
  
• Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma
  ClinicalTrials.gov Identifier: NCT00500539 - Recruiting
  Asthma
  
• An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00162227 - Recruiting
  HIV Infection
  
• Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition
  ClinicalTrials.gov Identifier: NCT00491894 - Recruiting
  Sialorrhea; Cerebral Palsy; Neurological Conditions; Mental Retardation
  
• A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
  ClinicalTrials.gov Identifier: NCT00281606 - Not yet recruiting
  HIV Infection
  
• Enbrel Liquid Immunogenicity Protocol
  ClinicalTrials.gov Identifier: NCT00249041 - Completed
  Rheumatoid Arthritis
  
• Study of an Oral Tyrosine Kinase Inhibitor of VEGFR-2 for the Treatment of Advanced Stage Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00074854 - Completed
  Lung Cancer; Carcinoma, Non-Small-Cell Lung
  
• Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)
  ClinicalTrials.gov Identifier: NCT00192387 - Completed
  Influenza
  
• Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects
  ClinicalTrials.gov Identifier: NCT00000362 - Terminated
  Pneumonia, Aspiration
  
• To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)
  ClinicalTrials.gov Identifier: NCT00345956 - Completed
  Gastroenteritis; Rotavirus Infections
  
• Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.
  ClinicalTrials.gov Identifier: NCT00192400 - Completed
  Healthy
  
• Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway
  ClinicalTrials.gov Identifier: NCT00248755 - Completed
  Cystic Fibrosis
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)
  ClinicalTrials.gov Identifier: NCT00192231 - Completed
  Influenza
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children
  ClinicalTrials.gov Identifier: NCT00192322 - Completed
  Influenza
  
• Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
  ClinicalTrials.gov Identifier: NCT00192374 - Completed
  Healthy
  
• A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)
  ClinicalTrials.gov Identifier: NCT00240929 - Completed
  -Unhealthy Children With a History of Prematurity
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00192192 - Completed
  Influenza
  
• Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00413426 - Completed
  Healthy
  
• A Randomized, Double-Blind Trial To Assess The Safety And Relative Efficacy Of CAIV-T Against Inactivated Influenza Vaccine In Children 6-59 Months Of Age
  ClinicalTrials.gov Identifier: NCT00128167 - Completed
  Influenza
  
• Biomarkers of Homeopathy in Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00065702 - Completed
  Fibromyalgia
  
• Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
  ClinicalTrials.gov Identifier: NCT00000302 - Completed
  Heroin Dependence
  
• Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 –
  ClinicalTrials.gov Identifier: NCT00192166 - Completed
  Influenza
  
• Treatment for Subjects with Active Rheumatoid Arthritis (RA)
  ClinicalTrials.gov Identifier: NCT00110903 - Completed
  Rheumatoid Arthritis
  
• Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
  ClinicalTrials.gov Identifier: NCT00567385 - Completed
  Growth Hormone Deficiency (GHD)
  
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
  ClinicalTrials.gov Identifier: NCT00192153 - Completed
  Influenza
  
• A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00160602 - Completed
  Rheumatoid Arthritis
  
• Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00002922 - Completed
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• Determinants in Antidepressant Outcomes
  ClinicalTrials.gov Identifier: NCT00108316 - Terminated
  Depression